The Worldwide Competent Cells Industry is Projected to Reach $3.2 Billion by 2030: Need for Faster Characterization Proteins & More Efficient Protein Expression Spurs the Use of Competent Cells

PR Newswire
·5 min read

DUBLIN, Feb. 3, 2023 /PRNewswire/ -- The "Competent Cells - Global Strategic Business Report" report has been added to  ResearchAndMarkets.com's offering.

Research and Markets Logo
Research and Markets Logo


The global market for Competent Cells estimated at US$1.7 Billion in the year 2022, is projected to reach a revised size of US$3.2 Billion by 2030, growing at a CAGR of 8% over the analysis period 2022-2030.

Chemically Competent Cells, one of the segments analyzed in the report, is projected to record 7.3% CAGR and reach US$2.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Electrocompetent Cells segment is readjusted to a revised 9.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $502.7 Million, While China is Forecast to Grow at 7.5% CAGR

The Competent Cells market in the U.S. is estimated at US$502.7 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$553.3 Million by the year 2030 trailing a CAGR of 7.5% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.2% and 6.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Select Competitors (Total 46 Featured) -

  • Agilent Technologies, Inc.

  • Bio-Rad Laboratories, Inc.

  • GenScript Biotech Corporation

  • Illumina, Inc.

  • Merck KgaA

  • New England Biolabs, Inc.

  • OriGene Technologies, Inc.

  • Promega Corporation

  • Qiagen NV

  • Takara Bio, Inc.

  • Thermo Fisher Scientific, Inc.

  • Zymo Research Corporation

What`s New for 2023?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

  • Global competitiveness and key competitor percentage market shares

  • Market presence across multiple geographies - Strong/Active/Niche/Trivial

  • Online interactive peer-to-peer collaborative bespoke updates

  • Access to digital archives and Research Platform

  • Complimentary updates for one year

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights

  • World Market Trajectories

  • Competent Cells - Global Key Competitors Percentage Market Share in 2022 (E)

  • Competent Cells Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

  • Impact of Covid-19 and a Looming Global Recession

  • Clean-Label Starch Innovations

  • Chemically Competent Cells Segment Dominate in North America

  • Drivers & Restrains Summarized for Competent Cells Market

  • Cloning is Expected to Take the Largest Share of Competent Cells Market

  • Competent Cells Growth Outlook

  • Competent Cells Application Trends

  • Academic and Research Institutes Emerge as Largest End Users of Competent Cells Market

  • Leading Players in competent cells market

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Advancements in Molecular Cloning Drives Competent Cell Market

  • Drivers and Restraints Summarised

  • SGI-DNA Inc has Launched VmaxT Express Chemically Competent Cells .

  • Increasing Research on Cloning Demands Competent Cells Requirement

  • Increasing Intensity of Research and Technological Advancements Drives Market

  • Expanding Use of Protein Expression in the Production of Therapeutic Proteins Ranging from Insulin, Interferons & Interleukins to Drive Demand for Competent Cells: Global Market for Protein Expression (In US$ Million) for the Years 2017, 2019 & 2022

  • As the Foundation for Modern Biomolecular Research, Importance of Recombinant Proteins Spurs Demand for Competent Cells

  • Expanding Use of Protein Expression in the Production of Therapeutic Proteins Ranging from Insulin, Interferons & Interleukins to Drive Demand for Competent Cells: Global Market for Protein Expression (In US$ Million) for the Years 2017, 2019 & 2022

  • As Molecular Engineering Takes Huge Strides Forward in Manipulating & Harnessing the DNA for the Production of More Potent Therapies, Poised to Benefit are Ready-to-Use Competent Cells

  • Escherichia coli, the Most Widely Used Organism in the Expression of Cloned Proteins

  • Need for DNA Library Construction in Molecular Cloning Benefits Demand for Competent Cells

  • Need for Faster Characterization Proteins & More Efficient Protein Expression Spurs the Use of Competent Cells

  • Rise of Protein Expression Services Offering Flexible, Low-Cost Production of High-Quality, Bioactive Recombinant Proteins, Bodes Well for Market Growth

  • Higher Transformation Efficiencies Give Electroporation an Edge Over Chemical Methods

  • Heat Shock Treatment for Transformation of Competent Cells, Another Popular Method

  • Increased Investments in Life Sciences Research to Expand the Addressable Market Opportunity for Competent Cells

  • Rising Global Pharmaceutical R&D Offers a Fertile Environment for the Growth in Demand for Competent Cells: Global Pharmaceutical R&D (In US$ Billion) for the Years 2017, 2019, 2022 and 2024

  • Continuous Developments in Chemical Transformation Technologies to Benefit Market Growth

  • Rise in Non-Communicable Diseases, a Key Macro Trend Shaping Demand for Recombinant Enzymes & Proteins in Drug Discovery

  • Mind Bending Economic Burden of Noncommunicable Diseases (NCDs) Drives Urgent Investments in Drug Research & Development, Opening Up Opportunities for Competent Cells in Mass Production of Therapeutic Proteins: Cumulative Global Burden of NCDs (In US$ Trillion) for the Period 2011-2030

  • Cell Free Protein Expression & the Accompanying Promise of the Development of a Versatile Mass Production System for Protein Expression to Benefit Market Growth

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/s3cmsy-cells?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Cision
Cision

View original content:https://www.prnewswire.com/news-releases/the-worldwide-competent-cells-industry-is-projected-to-reach-3-2-billion-by-2030-need-for-faster-characterization-proteins--more-efficient-protein-expression-spurs-the-use-of-competent-cells-301738563.html

SOURCE Research and Markets

Latest Stories

  • Officials: No known connection between assailant, Olivet player shot last week in Ohio

    The Muskingum County Prosecutor's Office said the investigation had found "absolutely no ... connection to the victim or Muskingum University,"

  • ASHFORD SETS FIRST QUARTER EARNINGS RELEASE AND CONFERENCE CALL DATES

    Ashford Inc. (NYSE American: AINC) ("Ashford" or the "Company") today announced details for the release of its results for the first quarter ended March 31, 2023.

  • ASHFORD TRUST SETS FIRST QUARTER EARNINGS RELEASE AND CONFERENCE CALL DATES

    Ashford Hospitality Trust, Inc. (NYSE: AHT) ("Ashford Trust" or the "Company") today announced details for the release of its results for the first quarter ended March 31, 2023.

  • Regency Silver Announces Private Placement of up to CAD$2.0 Million at $0.40 per Share

    Regency Silver Corp. ("Regency Silver" or the "Company") (TSXV: RSMX) (OTCQB: RSMXF) is pleased to announce that it has arranged, subject to regulatory approval, a non-brokered private placement of up to 5 Million common shares at a price of CAD$0.40 per share for gross proceeds of CAD$2.0 Million. Closing of the private placement is anticipated to take place on or before Wednesday, March 29, 2023.

  • NETRAMARK ANNOUNCES CLOSING OF PRIVATE PLACEMENT

    NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (Frankfurt: 8TV) (OTC: AINMF), is pleased to announce that it has completed an initial closing of a non-brokered private placement in which it issued 1,981,867 units (the "Units") at a price of $0.37 per Unit for aggregate gross proceeds to NetraMark of $733,290. Each of the Units is comprised of one common share (each a "Common Share") and one-half common share purchase warrant (each a "Warrant"). Each Warrant entitles its holde

  • Tribe urges Army to speed up return of child's 1879 remains

    Federal authorities expect to return a 13-year-old boy's remains to his Native American tribe in South Dakota this fall, they said Friday. The Sisseton Wahpeton Oyate wrote to the head of the U.S. Army's cemetery office this week, demanding movement on their effort to have the remains of Amos LaFromboise repatriated from a graveyard at the Carlisle Barracks, a military facility in Pennsylvania. The letter from three lawyers with the Native American Rights Fund to Army Cemeteries Executive Director Karen Durham-Aguilera describes the child as the son of one of the tribe's most celebrated leaders, Chief Joseph LaFromboise, who signed an 1867 treaty that established their current reservation boundaries.

  • Commission decertifies ex-officers in Tyre Nichols case

    Decertification would prevent the officers charged in the beating death of Tyre Nichols from working in law enforcement in Tennessee.

  • NiSource Closes on Bond Offering

    NiSource Inc. (NYSE: NI) ("NiSource") closed today on its issuance of $750 million principal amount of notes due March 30, 2028. The 5-year senior, unsecured notes priced at 99.829% of the aggregate principal amount, with a coupon rate of 5.25%. The notes will accrue interest payable semi-annually in arrears on March 30 and September 30 of each year, beginning September 30, 2023.

  • Brazil's Lula 'fine' after pneumonia diagnosis, will travel to China Sunday

    Brazilian President Luiz Inacio Lula da Silva has been diagnosed with mild pneumonia and will delay a planned trip to China by a day, leaving on Sunday, the presidential palace and his doctor said. Lula's physician, Dr. Roberto Kalil, told Reuters that the president is in good health after undergoing hospital tests on Thursday night and is responding well to antibiotics. Lula was initially supposed to leave for China early Saturday for a visit aimed at refreshing ties with Brazil's largest export market.

  • Tesla Stock: Cathie Wood Sells $27 Million Of TSLA, Buys The Dip On Coinbase, Block

    Cathie Wood, ARK Invest unloaded $27 million in Tesla stock Thursday to buy the dip on Coinbase as shares tumbled following a SEC warning.

  • 'Loyal opposition?': Video of U.S. President Joe Biden meeting Conservative Leader Pierre Poilievre goes viral

    A video of U.S. President sharing a pointed remark while meeting Conservative Leader Pierre Poilievre at the House of Commons has gone viral.

  • WGC-Match Play: Hideki Matsuyama and Will Zalatoris WD on Friday with neck injury, illness

    Hideki Matsuyama has been dealing with a neck injury for months, and Will Zalatoris conceded his match on Friday due to an undisclosed illness.

  • Outreach workers are key to Mayor Bass' homeless initiative

    Outreach workers who provide social and medical services to homeless people in Los Angeles are key to the Inside Safe program.

  • Deutsche Bank share slide reignites worries among investors

    Worries over the financial strength of the sector persist, with Deutsche Bank shares down 14% at one point.

  • For NFL’s rule against negotiations with uncertified agents, enforcement is the challenge

    Most of the time, a player who represents himself in negotiations with teams is, in reality, represented by an agent who is not certified by the NFL Players Association. It’s rarely presented that way, either because the player prefers the perception that he’s doing it alone — or because the player realizes the importance of [more]

  • Venezuelan gangster with million-dollar bounty killed, authorities say

    A man accused of leading a prominent drug-running ring has been killed by authorities in northeastern Venezuela, the country's interior minister said on Friday. Carlos Enrique Gomez Rodriguez, also known as "El Conejo" or "The Rabbit," was wanted for a string of crimes, leading police to offer $1 million for information related to his whereabouts last month. Gomez was killed Thursday in the town of Irapa, in Sucre state, Interior Minister Remigio Ceballos said in a brief broadcast on state television.

  • FDA Roundup: March 24, 2023

    Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:

  • Prime Minister Trudeau and President Biden Joint Statement

    Canada and the United States celebrate our progress under the Roadmap for a Renewed U.S.-Canada Partnership over the past two years and reaffirm our historic alliance, steadfast friendship, and commitment to overcome the daunting challenges of today and realize the full potential of the relationship in the future. Our enduring partnership is based on a mutual commitment to shared security, shared prosperity, and shared democratic values, including the importance of fighting climate change and an

  • Statement from the Chief Public Health Officer of Canada on World TB Day

    Every year, March 24th is an opportunity to raise awareness about the health, social and economic impacts of tuberculosis (TB). Today, on World TB Day 2023, the theme "Yes! We can end TB!" is a message of hope and encouragement for high-level leadership, action and collaboration.

  • Packers GM Brian Gutekunst attends Penn State pro day

    Brian Gutekunst's next stop on the pro day circuit: Penn State on Friday.